04.06.2013 Views

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

espiratory tract irritation (RTI ) (e.g. electrophysiological responses, biomarkers of<br />

inflammation in nasal or bronchoalveolar lavage fluids;<br />

(c) The symptoms observed in humans should also be typical of those that would be<br />

produced in <strong>the</strong> exposed population ra<strong>the</strong>r than being an isolated idiosyncratic reaction<br />

or response triggered only in individuals with hypersensitive airways. Ambiguous<br />

reports simply of “irritation”should be excluded as this term is commonly used to<br />

describe a wide range of sensations including those such as smell, unpleasant taste, a<br />

tickling sensation, and dryness, w hich are outside <strong>the</strong> scope of this classification<br />

endpoint;<br />

(d) There are currently no validated animal tests that deal specifically with RTI, however,<br />

useful in<strong>for</strong>mation may be obtained from <strong>the</strong> single and repeated inhalation toxicity<br />

tests. For example, animal studies may provide useful in<strong>for</strong>mation in terms of clinical<br />

signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema,<br />

minimal inflammation, thickened mucous layer) which are reversible and may be<br />

reflective of <strong>the</strong> characteristic clinical symptoms described above. Such animal studies<br />

can be used as part of w eight of evidence evaluation;<br />

(e) This special classification would occur only when more severe organ effects including in<br />

<strong>the</strong> respiratory system are not observed.<br />

The <strong>GHS</strong> criteria <strong>for</strong> specific target organ toxicity (single exposure) Category 3 “narcotic<br />

effects” are as follows.<br />

【<strong>GHS</strong> 2 nd revised edition】(3.8.2.2.2)<br />

The criteria <strong>for</strong> narcotic effects as Category 3 are:<br />

(a) Central nervous system depression including narcotic effects in humans such as<br />

drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and<br />

vertigo are included. These effects can also be manifested as severe headache or<br />

nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired<br />

memory function, deficits in perception and coordination, reaction time, or sleepiness;<br />

(b) Narcotic effects observed in animal studies may include lethargy, lack of coordination<br />

righting reflex, narcosis, and ataxia. If <strong>the</strong>se effects are not transient in nature, <strong>the</strong>n<br />

<strong>the</strong>y should be considered <strong>for</strong> classification as Category 1 or 2.<br />

(3)Items on in<strong>for</strong>mation sources and data<br />

* <strong>Classification</strong> procedure can be referred to "3-1-1 Sources of In<strong>for</strong>mation available <strong>for</strong><br />

classification".<br />

A) Data availability<br />

Sufficient in<strong>for</strong>mation <strong>for</strong> classification cannot be obtained from simple descriptions in<br />

173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!